BioFirst's core business is to research, develop, manufacture and market innovative biotech products. BioFirst obtained the exclusive global rights for innovative technologies from academia. Through internal R&D expertise and efforts, BioFirst proceed with product development and commercialize. We look for appropriate partners or licensee of our technologies after reaching certain milestones, in order to use resources effectively and accelerate the return of investment.

BioFirst focuses on the clinical use of biomaterial, and targets specific clinical indications with unmet medical needs and limited competition. Since development of advanced medical device does not require clinical trials in phases, it will be the focus of our business development.